1. Home
  2. ABUS vs PNTG Comparison

ABUS vs PNTG Comparison

Compare ABUS & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

N/A

Current Price

$4.71

Market Cap

884.7M

Sector

Health Care

ML Signal

N/A

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

N/A

Current Price

$34.13

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABUS
PNTG
Founded
2005
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.7M
1.0B
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
ABUS
PNTG
Price
$4.71
$34.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$5.00
$36.83
AVG Volume (30 Days)
2.2M
276.3K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
13.64
20.00
EPS
N/A
0.84
Revenue
$6,171,000.00
$947,705,000.00
Revenue This Year
$125.30
$24.09
Revenue Next Year
N/A
$7.99
P/E Ratio
N/A
$40.04
Revenue Growth
N/A
36.31
52 Week Low
$2.71
$21.74
52 Week High
$5.10
$35.00

Technical Indicators

Market Signals
Indicator
ABUS
PNTG
Relative Strength Index (RSI) 58.40 58.61
Support Level $4.18 $27.34
Resistance Level $5.01 $35.00
Average True Range (ATR) 0.22 1.62
MACD 0.03 0.10
Stochastic Oscillator 80.79 81.13

Price Performance

Historical Comparison
ABUS
PNTG

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Share on Social Networks: